Join us for this virtual seminar

  • Wednesday 21 October from 10:00 to 11:45
  • Virtual seminar organized through MS Teams platform

As gene therapies move towards commercialization, a robust, scalable and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical assets can be rapidly developed. This seminar will address the current manufacturing challenges faced by the industry and offer potential solutions. Pall’s automated, end-to-end integrated platform solution coupled with our Accelerator℠ process development services (PDS) offers a holistic approach designed to decease risk, reduce costs and help speed you to market for your cell and gene therapy. Register now to discuss with our team of experts!

Program

  • 10:00 – 10:10 Welcome and Introduction
  • 10:10 – 10:30 Upstream capabilities and introduction to Pall Biotech single-use bioreactors portfolio
  • 10:30 – 10:45 Downstream solutions for viral vector manufacturing – Focus on process consumables
  • 10:45 – 11:00 Pall Integrated Solutions to increase speed to market
  • 11:00 – 11:10 Virtual tour of a GMP manufacturing facility for viral vectors
  • 11:10 – 11:30 Accelerator℠ Process Development Services: case study of clinical AAV9 manufacturing
  • 11:30 – 11:45 Q&A and wrap-up

Speakers

Lise Peeters, Cell Culture Specialist

Lise holds a PhD degree in Molecular Biology (KULeuven, Belgium) and has over 10 years of experience working for the biopharmaceutical industry, the last year within Pall. As a cell culture specialist, she is instrumental in the development of upstream bioprocessing, and therefore mainly focussing on bioreactors.

Jean-Pierre Lefevre, Senior Bioprocess Specialist

Jean-Pierre is the Senior Bioprocess Specialist for France, Spain and Portugal – covering the technical support for biotech downstream processes. With his industrial Microbiology MSc he joined Pall Biotech 26 years ago, developing an extensive experience in clarification, tangential filtration and chromatography

Willem Van der Niet, Integrated Solutions Manager

Willem is the Biotech Integrated Solutions Manager for Spain, The Benelux, Scandinavia and a large CMO – covering full end-to-end solutions. With his extensive experience and knowledge of the Biopharmaceutical industry, 35 years+, he can support you providing with solutions for any type of process.

Salete Figuereido, Business Development Manager

Graduated from Porto University in Portugal (FEUP) in chemical engineering with a specialization in biotechnology. She started her career as technical sales engineer in the chemistry market and joined Pall in 2016 as account mananger for the FTAP division. She is now Business Development Manager at Pall Biotech.

Moderator

Elodie Ly, Regional Marketing Manager EMEA

Elodie is Regional Marketing Manager in Europe for Pall Biotech. She has a Ph.D. in Biomedical Engineering and a Master’s Degree in Instrumentation for Biotechnologies (Grenoble INP, France). She has more than 10 years of experience in the Life Science market and has occupied different roles in business development and product marketing in a global environment.

To register, contact directly Elodie Ly (elodie_ly@pall.com)

Fuente: Pall Biotech

https://www.pall.com/
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Diapositiva de Fotos